Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-05-29
2010-06-29
Wollenberger, Louis (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
Reexamination Certificate
active
07745610
ABSTRACT:
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to CDK11.
REFERENCES:
patent: 5958773 (1999-09-01), Monia
patent: 6001992 (1999-12-01), Ackerman
patent: 6111086 (2000-08-01), Scaringe
patent: 6172216 (2001-01-01), Bennett et al.
patent: 6291642 (2001-09-01), Weinstein
patent: 6506559 (2003-01-01), Fire et al.
patent: 6566127 (2003-05-01), Pavco
patent: 6590093 (2003-07-01), Scaringe
patent: 6965025 (2005-11-01), Gaarde et al.
patent: 6994979 (2006-02-01), Reed
patent: 7022831 (2006-04-01), Reed
patent: 7022837 (2006-04-01), Harding
patent: 7033830 (2006-04-01), Karras
patent: 7157570 (2007-01-01), Yen
patent: 7176304 (2007-02-01), McSwiggen
patent: 7250496 (2007-07-01), Bentwich
patent: 7399853 (2008-07-01), Freier
patent: 7507811 (2009-03-01), Khvorova
patent: 7511132 (2009-03-01), Khvorova
patent: 7514550 (2009-04-01), Khvorova
patent: 7521191 (2009-04-01), Khvorova
patent: 7541453 (2009-06-01), Khvorova
patent: 7550572 (2009-06-01), Khvorova
patent: 7569684 (2009-08-01), Khvorova
patent: 7576196 (2009-08-01), Khvorova
patent: 7576197 (2009-08-01), Khvorova
patent: 7579457 (2009-08-01), Khvorova
patent: 7579458 (2009-08-01), Khvorova
patent: 7582746 (2009-09-01), Khvorova
patent: 7582747 (2009-09-01), Khvorova
patent: 7589191 (2009-09-01), Khvorova
patent: 7592442 (2009-09-01), Khvorova
patent: 7592443 (2009-09-01), Khvorova
patent: 7592444 (2009-09-01), Khvorova
patent: 7595387 (2009-09-01), Leake
patent: 7595388 (2009-09-01), Khvorova
patent: 7595389 (2009-09-01), Khvorova
patent: 7598369 (2009-10-01), Khvorova
patent: 7598370 (2009-10-01), Khvorova
patent: 7605250 (2009-10-01), Khvorova
patent: 7605252 (2009-10-01), Khvorova
patent: 7608706 (2009-10-01), Khvorova
patent: 7608707 (2009-10-01), Khvorova
patent: 7612196 (2009-11-01), Khvorova
patent: 7615541 (2009-11-01), Khvorova
patent: 2002/0081578 (2002-06-01), Plowman et al.
patent: 2002/0086321 (2002-07-01), Craig
patent: 2002/0086356 (2002-07-01), Tuschl et al.
patent: 2002/0150945 (2002-10-01), Finney et al.
patent: 2003/0087259 (2003-05-01), Clancy et al.
patent: 2003/0105051 (2003-06-01), McSwiggen
patent: 2003/0143732 (2003-07-01), Fosnaugh
patent: 2003/0157030 (2003-08-01), Davis et al.
patent: 2003/0224512 (2003-12-01), Dobie
patent: 2003/0228597 (2003-12-01), Cowsert
patent: 2004/0006365 (2004-01-01), Brady
patent: 2004/0029275 (2004-02-01), Brown et al.
patent: 2004/0054155 (2004-03-01), Woolf et al.
patent: 2004/0063654 (2004-04-01), Davis et al.
patent: 2004/0077574 (2004-04-01), Klinghoffer
patent: 2004/0101857 (2004-05-01), Ward
patent: 2004/0101915 (2004-05-01), Deveraux
patent: 2004/0102391 (2004-05-01), Dean
patent: 2004/0180357 (2004-09-01), Reich et al.
patent: 2004/0191818 (2004-09-01), O'Toole
patent: 2004/0192629 (2004-09-01), Xu et al.
patent: 2004/0204380 (2004-10-01), Ackerman
patent: 2004/0219671 (2004-11-01), McSwiggen
patent: 2004/0248296 (2004-12-01), Beresford
patent: 2004/0248299 (2004-12-01), Jayasena et al.
patent: 2004/0259247 (2004-12-01), Tuschl et al.
patent: 2005/0048529 (2005-03-01), McSwiggen
patent: 2005/0107328 (2005-05-01), Wyatt
patent: 2005/0130181 (2005-06-01), McSwiggen
patent: 2005/0176025 (2005-08-01), McSwiggen et al.
patent: 2005/0181382 (2005-08-01), Zamore et al.
patent: 2005/0186586 (2005-08-01), Zamore et al.
patent: 2005/0227935 (2005-10-01), McSwiggen
patent: 2005/0239731 (2005-10-01), McSwiggen et al.
patent: 2005/0245475 (2005-11-01), Khvorova
patent: 2005/0272680 (2005-12-01), Bhanot
patent: 2006/0025372 (2006-02-01), Bhanot
patent: 2006/0069056 (2006-03-01), Feinstein et al.
patent: 2006/0286575 (2006-12-01), Farrell
patent: 2007/0031844 (2007-02-01), Khvorova et al.
patent: 2007/0254850 (2007-11-01), Lieberman
patent: 2007/0269395 (2007-11-01), Christiano
patent: 2007/0275465 (2007-11-01), Woppman
patent: 2007/0281901 (2007-12-01), Yanni
patent: 2008/0113351 (2008-05-01), Naito
patent: 2008/0124370 (2008-05-01), Marx
patent: WO9800532 (1998-01-01), None
patent: WO9938965 (1999-08-01), None
patent: WO9954459 (1999-10-01), None
patent: WO0032765 (1999-12-01), None
patent: WO0020645 (2000-04-01), None
patent: WO0021559 (2000-12-01), None
patent: WO0076497 (2000-12-01), None
patent: WO 0244321 (2002-06-01), None
patent: WO03035869 (2003-05-01), None
patent: WO03035870 (2003-05-01), None
patent: WO03046176 (2003-06-01), None
patent: WO04046324 (2003-06-01), None
patent: WO03070897 (2003-08-01), None
patent: WO03070910 (2003-08-01), None
patent: WO03070969 (2003-08-01), None
patent: WO03646625 (2003-08-01), None
patent: WO03072704 (2003-09-01), None
patent: WO2004031237 (2004-04-01), None
patent: WO2004048511 (2004-06-01), None
patent: WO2004090105 (2004-10-01), None
patent: WO2004094636 (2004-11-01), None
patent: WO2005001043 (2005-01-01), None
patent: WO2005078095 (2005-08-01), None
patent: WO2005089224 (2005-09-01), None
patent: WO2005117991 (2005-12-01), None
patent: WO2006015389 (2006-02-01), None
patent: WO2006110813 (2006-10-01), None
Kumar, High-Throughput Selection of Effective RNAi Probes for Gene Silencing (2003).
Laitala et al., Inhibition of Bone Resorption in Vitro by Antisense RNA and DNA Molecules Targeted against Carbonic Anhydrase II or Two Subuntis of Vacuolar H + ATPase, Journal of Clinical Investigation 1994, vol. 93, pp. 2311-2318.
Lapidot-Lifson, et al. (1992) Cloning and Antisense Oligodeoxynucleotide Inhibition of a Human Homolog of cdc2 required in Hematopoiesis, Proc. Natl. Acad. Sci. vol. 89, pp. 579-583.
Levenkova, Gene specific siRNA selector, Bioinofrmatics vol. 20, pp. 430-432 (2004).
Lindgren, et al. (2002) Contribution of Known and Unknown Susceptibility Genes to Early-Onset Diabetes in Scandinavia, Diabetes vol. 51, 1609-1617.
Lu, et al., The Human AQP4 gene: Definition of the locus encoding two water channel polypeptides in brain, Proc. Natl Acad. Sci vol. 93, pp. 10908-10912 (Oct. 1996).
Marathi, RAD1, a Human Structural Homolog of the Schizosaccharomyces pombe RAD1 Cell Cycle Checkpoint Gene, Genomcs 54, 344-347 (1998).
Miller, V M et al., “Allele-specific silencing of dominant disease genes” Proceedings of the National Acadamy of Sciences of USA, vol. 100, No. 12, Jun. 10, 2003, pp. 7195-7200 , XP002276730.
Miyagashi et al. (2003) Comparison of the Suppressive Effects of Antisense Oligonucleotides and siRNAs Directed Against the Same Targets in Mammalian Cells. Antisense and Nucleic Acid Drug Development 13:1-7.
Murphy, et al. (2000) Synucleins are Developmentally Expressed, and Alpha-Synuclein Regulates the Size of the Presynaptic Vesicular Pool in Primary Hippocampal Neurons. The Journal of Neuroscience, vol. 20(9):3214-20.
Naito, siDirect: highly effective, target specific siRNA design software for mammalian RNA interference, Nucleic Acids Research vol. 32, W124-129 (2004).
NCBI Nucleotide Result for NM-002609, http://www.ncbi.nlm.nih.gov/sites/entrez, accessed on Jul. 14, 2008.
NCBI Sequence Viewer v2.0 for NM-004438, http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=45439363, accessed on Jul. 3, 2008.
Oishi, et al., Identification and Characterization of PKN Beta, a Novel Isoform of Protein Kinase PKN: Expression and Arachiodonic Acid Dependency Are Different from those of PKN alpha, 1999 Biochemical and Biophysical Research Communcation, 261, pp. 808-814.
Olie et al, A Novel Antisense Oligonucleotide Targeting Survivin Expression Induces Apoptosis and Sensitizes Lung Cancer Cells to Chemotherapy, Cancer Research 2000, vol. 60: pp. 2805-2809.
Pan, et al. (2005) Calmodulin-dependent protein kinase IV regulates nuclear export of Cabin1 during T-cell activation, The EMBO Journal, 24, 2104-2113.
Promega siRNA Target Designer-Version 1.51, http:///www.promega.com/siRNADesigner/program/default.asp. Accessed Jun. 24, 2008.
Promega siRNA Target Designer-Version 1.1, http:///www.prome
Khvorova Anastasia
Leake Devin
Marshall William
Read Steven
Reynolds Angela
Dharmacon, Inc.
Kalow & Springut LLP
Locke, Esq. Scott D.
Wollenberger Louis
LandOfFree
siRNA targeting cyclin dependent kinase 11 (CDK11) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with siRNA targeting cyclin dependent kinase 11 (CDK11), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and siRNA targeting cyclin dependent kinase 11 (CDK11) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4234730